Photo: Sartorius

ACTIP member companies

Astra Zeneca – United Kingdom
Bayer AG – Wuppertal Germany
BioMarin – Ireland
Boehringer Ingelheim Pharma GmbH KG & Co. KG – Germany
Byondis – The Netherlands
CEVEC Pharmaceuticals – Germany
Clean Cells – France
CSL Behring– Germany
Cytiva  – Sweden
FUJIFILM Diosynth Biotechnologies – Denmark
ExcellGene SA – Switzerland
ExpreS²ion Biotechnologies – Denmark
GSK Vaccines – Belgium
Horizon Discovery – United Kingdom
iBET – Portugal
Ichnos Sciences SA  – Switzerland
Janssen Vaccines – The Netherlands
Lonza Biologics – United Kingdom
Lonza Ibex- Switzerland
Merck Life Science – Germany

Merck Life Science – United Kingdom
Merck Healthcare – Switzerland
MorphoSys AG – Germany
– The Netherlands
NaoBios – France
NIBRT – Ireland
Novo Nordisk A/S – Denmark
Patheon Biologics – The Netherlands
Polpharma Biologics – Poland
Rentschler Biopharma SE – Germany
Roche Diagnostics GmbH – Germany
Sanofi Aventis – Germany
Sanofi Genzyme  – Belgium
Sartorius Stedim Cellca GmbH – Germany
SOBI AG – Switzerland
Symphogen A/S – Denmark
Teva Biotech – Germany
4Tune Engineering – Portugal
UCB – Switzerland
UniQure – The Netherlands

Honorary Members

Prof. Dr. Michael Comer – Ireland
Dr. Helma Hermans – Spain


Services of the European Commission DG Research: Dr. Jürgen Sautter

European Society for Animal Cell Technology, ESACT Chairman:
Prof. Dr. Paula M. Alves, iBET

How to become a member

ACTIP membership is open to companies located in Europe, engaged in industrial use of animal cell culture for production of proteins and/or other substances, the production of vaccines or involved in gene therapy. Furthermore, the company should be making significant research and development efforts in one or all of these fields.
A company wishing to apply for membership should contact the ACTIP secretariat on how to present itself. Membership applications are voted on by the members during the next plenary meeting.

©2020 ACTIP Privacy Policy

Log in with your credentials

Forgot your details?